|
|
Volumn 18, Issue 12, 2000, Pages 1238-1239
|
|
HGS Targets Patent-Expiring Drugs
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYBRID PROTEIN;
RECOMBINANT INTERFERON;
SERUM ALBUMIN;
ARTICLE;
BIOTECHNOLOGY;
CHEMISTRY;
DRUG APPROVAL;
DRUG INDUSTRY;
HALF LIFE TIME;
HEPATITIS C;
HUMAN;
LEGAL ASPECT;
PATENT;
BIOTECHNOLOGY;
DRUG INDUSTRY;
HALF-LIFE;
HEPATITIS C;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
INVESTIGATIONAL NEW DRUG APPLICATION;
PATENTS;
RECOMBINANT FUSION PROTEINS;
SERUM ALBUMIN;
|
|
EID: 0034540940
PISSN: 0733222X
EISSN: None
Source Type: Journal
DOI: 10.1038/82333 Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|
